Cardiac magnetic resonance in hypertrophic cardiomyopathy

JACC: Cardiovascular Imaging

Volumn 4, Issue 10, 2011, Pages 1123-1137

  To, Andrew C Y ^a   Dhillon, Ashwat ^a   Desai, Milind Y ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

cardiac magnetic resonance; hypertrophic cardiomyopathy; late gadolinium enhancement

Indexed keywords

AORTA STENOSIS; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; DIAGNOSTIC TEST ACCURACY STUDY; GENE MUTATION; HEALTH CARE PLANNING; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART PAPILLARY MUSCLE; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; MYOMECTOMY; PRIORITY JOURNAL; PROGNOSIS; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 80054093923     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2011.06.022     Document Type: Review

References (79)

1. B.J. Maron Hypertrophic cardiomyopathy: a systematic review JAMA 287 2002 1308 1320 (Pubitemid 34250486)
2. P. Elliott, and W.J. McKenna Hypertrophic cardiomyopathy Lancet 363 2004 1881 1891 (Pubitemid 38748646)
3. A.J. Marian, and R. Roberts The molecular genetic basis for hypertrophic cardiomyopathy J Mol Cell Cardiol 33 2001 655 670 (Pubitemid 32538979)
4. J.G. Seidman, and C. Seidman The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms Cell 104 2001 557 567 (Pubitemid 32201950)
5. J.M. Bos, J.A. Towbin, and M.J. Ackerman Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy J Am Coll Cardiol 54 2009 201 211
6. B.J. Maron, W.J. McKenna, and G.K. Danielson American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J Am Coll Cardiol 42 2003 1687 1713 (Pubitemid 37383745)
7. P.M. Elliott, J. Poloniecki, and S. Dickie Sudden death in hypertrophic cardiomyopathy: identification of high risk patients J Am Coll Cardiol 36 2000 2212 2218
8. I. Christiaans, K. van Engelen, and I.M. van Langen Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers Europace 12 2010 313 321
9. J.A. Lima, and M.Y. Desai Cardiovascular magnetic resonance imaging: current and emerging applications J Am Coll Cardiol 44 2004 1164 1171 (Pubitemid 39208868)
10. D.H. Kwon, R.M. Setser, and Z.B. Popovic Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study Int J Cardiovasc Imaging 24 2008 617 625
11. A.S. Adabag, B.J. Maron, and E. Appelbaum Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance J Am Coll Cardiol 51 2008 1369 1374 (Pubitemid 351443083)
12. R. Rubinshtein, J.F. Glockner, and S.R. Ommen Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy Circ Heart Fail 3 2010 51 58
13. R. O'Hanlon, A. Grasso, and M. Roughton Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 867 874
14. O. Bruder, A. Wagner, and C.J. Jensen Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 875 887
15. R.C. Hendel, M.R. Patel, and C.M. Kramer ACCF/ACR/SCCT/SCMR/ASNC/NASCI/ SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology J Am Coll Cardiol 48 2006 1475 1497
16. S.F. Nagueh, S.M. Bierig, and M.J. Budoff American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography J Am Soc Echocardiogr 24 2011 473 498
17. M.Y. Desai, S.R. Ommen, W.J. McKenna, H.M. Lever, and P.M. Elliott Imaging phenotype versus genotype in hypertrophic cardiomyopathy Circ Cardiovasc Imaging 4 2011 156 168
18. M.S. Maron, I. Olivotto, and S. Betocchi Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy N Engl J Med 348 2003 295 303 (Pubitemid 36119984)
19. D.H. Kwon, R.M. Setser, and M. Thamilarasan Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy Heart 94 2008 1295 1301
20. H.G. Klues, W.C. Roberts, and B.J. Maron Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy Significance in producing left ventricular outflow obstruction Circulation 84 1991 1188 1197
21. M.W. Kon, E.D. Grech, S.Y. Ho, J.G. Bennett, and P.D. Collins Anomalous papillary muscle as a cause of left ventricular outflow tract obstruction in an adult Ann Thorac Surg 63 1997 232 234 (Pubitemid 27039073)
22. C.J. Harrigan, E. Appelbaum, and B.J. Maron Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy Am J Cardiol 101 2008 668 673 (Pubitemid 351635561)
23. M.D. Hope, A.K. Meadows, and T.A. Hope Clinical evaluation of aortic coarctation with 4D flow MR imaging J Magn Reson Imaging 31 2010 711 718
24. C.K. Macgowan, C.J. Kellenberger, J.S. Detsky, K. Roman, and S.J. Yoo Real-time Fourier velocity encoding: an in vivo evaluation J Magn Reson Imaging 21 2005 297 304 (Pubitemid 40280125)
25. K.R. O'Brien, S.G. Myerson, B.R. Cowan, A.A. Young, and M.D. Robson Phase contrast ultrashort TE: a more reliable technique for measurement of high-velocity turbulent stenotic jets Magn Reson Med 62 2009 626 636
26. N. Fujita, A.F. Chazouilleres, and J.J. Hartiala Quantification of mitral regurgitation by velocity-encoded cine nuclear magnetic resonance imaging J Am Coll Cardiol 23 1994 951 958 (Pubitemid 24090882)
27. W.G. Hundley, H.F. Li, and J.E. Willard Magnetic resonance imaging assessment of the severity of mitral regurgitation Comparison with invasive techniques Circulation 92 1995 1151 1158
28. W.L. Henry, C.E. Clark, and S.E. Epstein Asymmetric septal hypertrophy (ASH): the unifying link in the IHSS disease spectrum Observations regarding its pathogenesis, pathophysiology, and course Circulation 47 1973 827 832
29. W.L. Henry, C.E. Clark, and S.E. Epstein Asymmetric septal hypertrophy Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS Circulation 47 1973 225 233
30. M.S. Maron, B.J. Maron, and C. Harrigan Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance J Am Coll Cardiol 54 2009 220 228
31. I. Olivotto, F. Girolami, and M.J. Ackerman Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy Mayo Clin Proc 83 2008 630 638 (Pubitemid 351810562)
32. C. Rickers, N.M. Wilke, and M. Jerosch-Herold Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy Circulation 112 2005 855 861 (Pubitemid 41170072)
33. J.C. Moon, N.G. Fisher, W.J. McKenna, and D.J. Pennell Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography Heart 90 2004 645 649 (Pubitemid 38668538)
34. M.S. Maron, J.J. Finley, and J.M. Bos Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy Circulation 118 2008 1541 1549
35. M.S. Maron, T.H. Hauser, and E. Dubrow Right ventricular involvement in hypertrophic cardiomyopathy Am J Cardiol 100 2007 1293 1298 (Pubitemid 47500158)
36. A. Rudolph, H. Abdel-Aty, and S. Bohl Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling J Am Coll Cardiol 53 2009 284 291
37. C.F. Azevedo, M. Nigri, and M.L. Higuchi Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease J Am Coll Cardiol 56 2010 278 287
38. F. Grothues, G.C. Smith, and J.C. Moon Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy Am J Cardiol 90 2002 29 34 (Pubitemid 34671198)
39. S.E. Petersen, J.B. Selvanayagam, and J.M. Francis Differentiation of athlete's heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance J Cardiovasc Magn Reson 7 2005 551 558 (Pubitemid 40770332)
40. S. Basavarajaiah, M. Wilson, and S. Junagde Physiological left ventricular hypertrophy or hypertrophic cardiomyopathy in an elite adolescent athlete: role of detraining in resolving the clinical dilemma Br J Sports Med 40 2006 727 729 discussion 729 (Pubitemid 44197158)
41. J.C. Moon, B. Sachdev, and A.G. Elkington Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease Evidence for a disease specific abnormality of the myocardial interstitium Eur Heart J 24 2003 2151 2155 (Pubitemid 37486535)
42. M. Puvaneswary, F. Joshua, and S. Ratnarajah Idiopathic hypereosinophilic syndrome: magnetic resonance imaging findings in endomyocardial fibrosis Australas Radiol 45 2001 524 527 (Pubitemid 34595489)
43. J.P. Smedema, G. Snoep, and M.P. van Kroonenburgh Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis J Am Coll Cardiol 45 2005 1683 1690 (Pubitemid 40704507)
44. B.A. Austin, W.H. Tang, and E.R. Rodriguez Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis J Am Coll Cardiol Img 2 2009 1369 1377
45. A.M. Maceira, J. Joshi, and S.K. Prasad Cardiovascular magnetic resonance in cardiac amyloidosis Circulation 111 2005 186 193 (Pubitemid 40139730)
46. B.J. Maron, J.G. Seidman, and C.E. Seidman Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy J Am Coll Cardiol 44 2004 2125 2132 (Pubitemid 39576030)
47. T. Germans, A.A. Wilde, and P.A. Dijkmans Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations J Am Coll Cardiol 48 2006 2518 2523 (Pubitemid 44881223)
48. J.C. Moon, J. Mogensen, and P.M. Elliott Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I Heart 91 2005 1036 1040 (Pubitemid 41060010)
49. C.Y. Ho, B. Lopez, and O.R. Coelho-Filho Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy N Engl J Med 2010 552 563
50. C.Y. Ho, N.K. Sweitzer, and B. McDonough Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy Circulation 105 2002 2992 2997 (Pubitemid 34693832)
51. S.F. Nagueh, J. McFalls, and D. Meyer Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease Circulation 108 2003 395 398 (Pubitemid 36935530)
52. D.B. Ennis, F.H. Epstein, P. Kellman, L. Fananapazir, E.R. McVeigh, and A.E. Arai Assessment of regional systolic and diastolic dysfunction in familial hypertrophic cardiomyopathy using MR tagging Magn Reson Med 50 2003 638 642 (Pubitemid 37082091)
53. B.A. Austin, D.H. Kwon, N.G. Smedira, M. Thamilarasan, H.M. Lever, and M.Y. Desai Abnormally thickened papillary muscle resulting in dynamic left ventricular outflow tract obstruction: an unusual presentation of hypertrophic cardiomyopathy J Am Soc Echocardiogr 22 2009 105.e5 105.e6
54. D.H. Kwon, N.G. Smedira, M. Thamilarasan, B.W. Lytle, H. Lever, and M.Y. Desai Characteristics and surgical outcomes of symptomatic patients with hypertrophic cardiomyopathy with abnormal papillary muscle morphology undergoing papillary muscle reorientation J Thorac Cardiovasc Surg 140 2010 317 324
55. U.S. Valeti, R.A. Nishimura, and D.R. Holmes Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy J Am Coll Cardiol 49 2007 350 357 (Pubitemid 46097376)
56. W.G. van Dockum, A.M. Beek, and F.J. ten Cate Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy Circulation 111 2005 2503 2508 (Pubitemid 40696139)
57. J.C. Moon, E. Reed, and M.N. Sheppard The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy J Am Coll Cardiol 43 2004 2260 2264 (Pubitemid 38757595)
58. D.H. Kwon, N.G. Smedira, and E.R. Rodriguez Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia J Am Coll Cardiol 54 2009 242 249
59. M. Kitamura, M. Shimizu, and H. Ino Collagen remodeling and cardiac dysfunction in patients with hypertrophic cardiomyopathy: the significance of type III and VI collagens Clin Cardiol 24 2001 325 329 (Pubitemid 32285316)
60. K. Teraoka, M. Hirano, and H. Ookubo Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy Magn Reson Imaging 22 2004 155 161 (Pubitemid 38326634)
61. L. Choudhury, H. Mahrholdt, and A. Wagner Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy J Am Coll Cardiol 40 2002 2156 2164 (Pubitemid 36005903)
62. I. Olivotto, B.J. Maron, and E. Appelbaum Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy Am J Cardiol 106 2010 261 267
63. M.S. Maron, E. Appelbaum, and C.J. Harrigan Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy Circ Heart Fail 1 2008 184 191
64. J.C. Moon, W.J. McKenna, J.A. McCrohon, P.M. Elliott, G.C. Smith, and D.J. Pennell Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance J Am Coll Cardiol 41 2003 1561 1567 (Pubitemid 36543376)
65. P. Kellman, A.E. Arai, E.R. McVeigh, and A.H. Aletras Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement Magn Reson Med 47 2002 372 383 (Pubitemid 34116807)
66. G.D. Aquaro, V. Positano, and A. Pingitore Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy J Cardiovasc Magn Reson 12 2010 21
67. M. Spiewak, E.K. Biernacka, and L.A. Malek Quantitative assessment of pulmonary regurgitation in patients with and without right ventricular tract obstruction Eur J Radiol 2010 August 7 [E-pub ahead of print]
68. L.C. Amado, B.L. Gerber, and S.N. Gupta Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model J Am Coll Cardiol 44 2004 2383 2389 (Pubitemid 39647614)
69. Y. Amano, M. Takayama, and S. Kumita Contrast-enhanced myocardial T1-weighted scout (Look-Locker) imaging for the detection of myocardial damages in hypertrophic cardiomyopathy J Magn Reson Imaging 30 2009 778 784
70. A.S. Flett, M.P. Hayward, and M.T. Ashworth Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans Circulation 122 2010 138 144
71. I. Olivotto, M.S. Maron, and C. Autore Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy J Am Coll Cardiol 52 2008 559 566
72. T. Boonyasirinant, P. Rajiah, and R.M. Setser Aortic stiffness is increased in hypertrophic cardiomyopathy with myocardial fibrosis: novel insights in vascular function from magnetic resonance imaging J Am Coll Cardiol 54 2009 255 262
73. B.A. Austin, Z.B. Popovic, and D.H. Kwon Aortic stiffness independently predicts exercise capacity in hypertrophic cardiomyopathy: a multimodality imaging study Heart 96 2010 1303 1310
74. D.H. Kwon, N.G. Smedira, and Z.B. Popovic Steep left ventricle to aortic root angle and hypertrophic obstructive cardiomyopathy: study of a novel association using three-dimensional multimodality imaging Heart 95 2009 1784 1791
75. S.E. Petersen, M. Jerosch-Herold, and L.E. Hudsmith Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging Circulation 115 2007 2418 2425 (Pubitemid 46717964)
76. A. Esposito, F. De Cobelli, and G. Perseghin Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging Heart 95 2009 228 233
77. K. Abozguia, P. Elliott, and W. McKenna Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy Circulation 122 2010 1562 1569
78. S.J. Dong, J.H. MacGregor, and A.P. Crawley Left ventricular wall thickness and regional systolic function in patients with hypertrophic cardiomyopathy A three-dimensional tagged magnetic resonance imaging study Circulation 90 1994 1200 1209 (Pubitemid 24284441)
79. Z.B. Popovic, D.H. Kwon, and M. Mishra Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging J Am Soc Echocardiogr 21 2008 1299 1305